Equities researchers at Zacks Research lifted their FY2025 earnings per share estimates for shares of Bruker in a research ...

Bruker Co. (NASDAQ:BRKR – Get Free Report) has received a consensus rating of “Moderate Buy” from the eleven analysts that are presently covering the company, Marketbeat Ratings reports. Five research ...

The scientific instruments maker saw its shares rise 1% following the announcement. For the fourth quarter of 2024, Bruker posted adjusted earnings per share of $0.76, exceeding the analyst ...

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the research tools & consumables stocks, including ...

Scientific instrument company Bruker (NASDAQ:BRKR). will be reporting results tomorrow before market hours. Here’s what investors should know. Bruker met analysts’ revenue expectations last ...

Organic revenue growth - Bruker Scientific Instruments (BSI): 4.5% versus 3.3% estimated by two analysts on average. Organic revenue growth - Bruker Energy & Supercon Technologies (BEST): -2.8% ...

Q4 2024 reported revenues increased 14.6% year-over-year to $979.6 million, supported by acquisitions and 4.5% organic growth in the Bruker Scientific Instruments (BSI) segment. Non-GAAP diluted ...

(3) Bruker Scientific Instruments (BSI) revenue reflects the sum of the BSI BioSpin, CALID and Nano Segments as presented in our Annual Report on Form 10-K for the year ended December 31 ...

Bruker’s high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels.

Bruker’s high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels.